中国肿瘤临床
中國腫瘤臨床
중국종류림상
CHINESE JOURNAL OF CLINICAL ONCOLOGY
2014年
18期
1158-1162
,共5页
丛明华%李淑娈%程国威%代忠%刘金英%宋晨鑫%邓颖冰%刘微微%刘雪辉%李啸宇%卢世琰%于雷
叢明華%李淑孌%程國威%代忠%劉金英%宋晨鑫%鄧穎冰%劉微微%劉雪輝%李嘯宇%盧世琰%于雷
총명화%리숙련%정국위%대충%류금영%송신흠%산영빙%류미미%류설휘%리소우%로세염%우뢰
食管恶性肿瘤%同步放化疗%营养支持小组%预后%并发症
食管噁性腫瘤%同步放化療%營養支持小組%預後%併髮癥
식관악성종류%동보방화료%영양지지소조%예후%병발증
esophageal neoplasm%chemoradiotherapy%nutrition support team%prognosis%complications
目的:研究营养支持小组(NST)的参与是否对接受同步放化疗食管癌患者有益。方法:2012年6月至2013年12月因食管癌拟行放化疗患者40例入组,随机分为NST组和常规治疗组进行营养干预,观察放疗结束时患者营养状况、并发症发生率、治疗完成率、住院时间及住院费用。结果:NST组患者放疗结束时各项营养及血液指标均优于常规治疗组(P<0.05),并发症发生率低于常规治疗组(P<0.05),NST组全部按计划完成治疗,常规治疗组5例出现中断或延迟(P<0.05),NST组住院时间平均缩短3.8d(P<0.05),住院费用减少了6300元/人次(P>0.05)。结论:对于食管肿瘤放化疗患者,营养支持小组的参与有利于维持患者的营养状况,提高患者的治疗顺应性,缩短住院时间,降低住院费用。
目的:研究營養支持小組(NST)的參與是否對接受同步放化療食管癌患者有益。方法:2012年6月至2013年12月因食管癌擬行放化療患者40例入組,隨機分為NST組和常規治療組進行營養榦預,觀察放療結束時患者營養狀況、併髮癥髮生率、治療完成率、住院時間及住院費用。結果:NST組患者放療結束時各項營養及血液指標均優于常規治療組(P<0.05),併髮癥髮生率低于常規治療組(P<0.05),NST組全部按計劃完成治療,常規治療組5例齣現中斷或延遲(P<0.05),NST組住院時間平均縮短3.8d(P<0.05),住院費用減少瞭6300元/人次(P>0.05)。結論:對于食管腫瘤放化療患者,營養支持小組的參與有利于維持患者的營養狀況,提高患者的治療順應性,縮短住院時間,降低住院費用。
목적:연구영양지지소조(NST)적삼여시부대접수동보방화료식관암환자유익。방법:2012년6월지2013년12월인식관암의행방화료환자40례입조,수궤분위NST조화상규치료조진행영양간예,관찰방료결속시환자영양상황、병발증발생솔、치료완성솔、주원시간급주원비용。결과:NST조환자방료결속시각항영양급혈액지표균우우상규치료조(P<0.05),병발증발생솔저우상규치료조(P<0.05),NST조전부안계화완성치료,상규치료조5례출현중단혹연지(P<0.05),NST조주원시간평균축단3.8d(P<0.05),주원비용감소료6300원/인차(P>0.05)。결론:대우식관종류방화료환자,영양지지소조적삼여유리우유지환자적영양상황,제고환자적치료순응성,축단주원시간,강저주원비용。
Objective:To investigate whether the nutrition support team (NST) benefits esophageal carcinoma (EC) patients who are concurrently undergoing chemoradiotherapy. Methods: Between June 2012 and December 2013, 40 EC patients undergoing chemoradiotherapy were divided into the NST group and routine treatment (RT) group, with 20 patients in each group. At the end of chemoradiotherapy, the nutritional status, incidence of complications, and completion rates of radiotherapy were evaluated. The length of hospital stay (LOS) and cost were also compared between the two groups. Results:The nutrition and blood parameter values of the NST group were better (P<0.05) than those of the RT group. The incidence of complications was lower in the NST group (P<0.05) than that in the RT group. In addition, all patients in the NST group achieved the treatment plan, whereas five of the patients in the RT group interrupted or delayed the plan (P<0.05). The average LOS decreased by 3.8 d (P<0.05), and the hospitalization costs were reduced to 6300 RMB person-times (P>0.05) for the patients of the NST group. Conclusion: NST could maintain the nutritional status and improve the treatment compliance and tolerance of EC patients undergoing chemoradiotherapy, thereby shortening the LOS time and reducing the costs.